Protocol for AI-powered classification of IDH-mutant astrocytoma using GUIDE
Related Experiment Video
Updated: May 2, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
Jihong Tang1, Yimeng Qiao2, Yuyan Ruan2
1Division of Life Science, Department of Chemical and Biological Engineering, State Key Laboratory of Nervous System Disorders, The Hong Kong University of Science and Technology, Hong Kong SAR, China; SIAT-HKUST Joint Laboratory of Cell Evolution and Digital Health, HKUST Shenzhen-Hong Kong Collaborative Innovation Research Institute, Futian, Shenzhen, China.
Abstract:
Accurate identification of prognostic cancer subtypes remains challenging using routine diagnostics alone. Here, we present a protocol to obtain isocitrate dehydrogenase (IDH)-mutant astrocytoma subtype predictions using the generic utility for immune/mesenchymal-enriched (IME) diagnostic estimation (GUIDE). We describe steps for preparation of image and omics inputs, setup of the GUIDE Docker container, execution of subtype inference, and retrieval of standardized output files. GUIDE integrates histopathology images and multi-omics data and enables robust and flexible subtype classification under variable data availability. For complete details on the use and execution of this protocol, please refer to Tang et al.1.
More Related Videos
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014